Fries, Nadja
Constantinou, Agathi
Wretborn, Therése
Spångeus, Anna
Funding for this research was provided by:
Linköping University
Article History
Received: 31 August 2025
Accepted: 30 January 2026
First Online: 19 February 2026
Declarations
:
: The study protocol was reviewed and approved by the Swedish Ethical Review Authority (2021 − 01425, with an amendment 2022-02053-02). Informed consent was not required for this retrospective cohort study design.
: Not Applicable.
: Author AS has received speaker honoraria from UCB, Amgen, Astra Zeneca, and Tromp Medical, and has served on an advisory board for UCB. Authors NF, TW, and AC declare no conflicts of interest related to this work.